Table 2.
Procedural characteristics and the type of ERAF after catheter ablation in obese females and obese males.
| Females (n = 54) | Males (n = 60) | |||
|---|---|---|---|---|
| Cryoablation (n = 30) |
RF Ablation (n = 24) |
Cryoablation (n = 30) |
RF Ablation (n = 30) |
|
| Age, years | 63 ± 5.8 | ## 64 ± 6.9 | 62 ± 5.5 | 58 ± 9.0 * |
| BMI, kg/m2 | # 32.8 ± 3.5 | 29.8 ± 4.6 ** | 31.0 ± 2.1 | 30.5 ± 3.0 |
| Total procedure time, min | 105.2 ± 30.2 | 196.9 ± 52.1 **** | 98.6 ± 25.0 | 199.7 ± 37.7 **** |
| Fluoroscopy time, min | 15.5 ± 5.9 | 8.3 ± 3.3 **** | 14.3 ± 5.4 | 9.2 ± 4.5 *** |
| Application time, min | 30.5 ± 8.7 | 54.9 ± 16.2 **** | 28.2 ± 8.2 | 58.4 ± 17.5 **** |
| Application number | 8.2 ± 2.4 | 47.2 ± 50.9 **** | 7.8 ± 2.3 | 25.2 ± 10.1 **** |
| ERAF, n (%) | 5 (17) | 5 (21) | 5 (17) | 8 (27) |
| Paroxysmal ERAF, n (%) | 4 (13) | 3 (12.5) | 3 (10) | 4 (13) |
| Persistent ERAF, n (%) | 1 (3) | 2 (8) | 2 (7) | 4 (13) |
* Significant difference CB vs. RF ablation, # significance difference females vs. males. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001; # p < 0.05, ## p < 0.05.